Literature DB >> 24850729

Human immunodeficiency virus reverse transcriptase displays dramatically higher fidelity under physiological magnesium conditions in vitro.

Vasudevan Achuthan1, Brian J Keith2, Bernard A Connolly2, Jeffrey J DeStefano3.   

Abstract

UNLABELLED: The fidelity of human immunodeficiency virus (HIV) reverse transcriptase (RT) has been a subject of intensive investigation. The mutation frequencies for the purified enzyme in vitro vary widely but are typically in the 10(-4) range (per nucleotide addition), making the enzyme severalfold less accurate than most polymerases, including other RTs. This has often been cited as a factor in HIV's accelerated generation of genetic diversity. However, cellular experiments suggest that HIV does not have significantly lower fidelity than other retroviruses and shows a mutation frequency in the 10(-5) range. In this report, we reconcile, at least in part, these discrepancies by showing that HIV RT fidelity in vitro is in the same range as cellular results from experiments conducted with physiological (for lymphocytes) concentrations of free Mg(2+) (~0.25 mM) and is comparable to Moloney murine leukemia virus (MuLV) RT fidelity. The physiological conditions produced mutation rates that were 5 to 10 times lower than those obtained under typically employed in vitro conditions optimized for RT activity (5 to 10 mM Mg(2+)). These results were consistent in both commonly used lacZα complementation and steady-state fidelity assays. Interestingly, although HIV RT showed severalfold-lower fidelity under high-Mg(2+) (6 mM) conditions, MuLV RT fidelity was insensitive to Mg(2+). Overall, the results indicate that the fidelity of HIV replication in cells is compatible with findings of experiments carried out in vitro with purified HIV RT, providing more physiological conditions are used. IMPORTANCE: Human immunodeficiency virus rapidly evolves through the generation and subsequent selection of mutants that can circumvent the immune response and escape drug therapy. This process is fueled, in part, by the presumably highly error-prone HIV polymerase reverse transcriptase (RT). Paradoxically, results of studies examining HIV replication in cells indicate an error frequency that is ~10 times lower than the rate for RT in the test tube, which invokes the possibility of factors that make RT more accurate in cells. This study brings the cellular and test tube results in closer agreement by showing that HIV RT is not more error prone than other RTs and, when assayed under physiological magnesium conditions, has a much lower error rate than in typical assays conducted using conditions optimized for enzyme activity.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24850729      PMCID: PMC4135932          DOI: 10.1128/JVI.00752-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

Review 1.  Retroviral mutation rates and reverse transcriptase fidelity.

Authors:  Evguenia S Svarovskaia; Sara R Cheslock; Wen-Hui Zhang; Wei-Shau Hu; Vinay K Pathak
Journal:  Front Biosci       Date:  2003-01-01

2.  Analyzing the fidelity of reverse transcription and transcription.

Authors:  J C Boyer; K Bebenek; T A Kunkel
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

3.  Nearest neighbor influences on DNA polymerase insertion fidelity.

Authors:  L V Mendelman; M S Boosalis; J Petruska; M F Goodman
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

4.  Hypermagnesemia does not increase brain intracellular magnesium in newborn swine.

Authors:  J B Gee; R J Corbett; J M Perlman; A R Laptook
Journal:  Pediatr Neurol       Date:  2001-10       Impact factor: 3.372

5.  The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene.

Authors:  L M Mansky
Journal:  Virology       Date:  1996-08-15       Impact factor: 3.616

6.  The effect of increased processivity on overall fidelity of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  L F Rezende; Y Kew; V R Prasad
Journal:  J Biomed Sci       Date:  2001 Mar-Apr       Impact factor: 8.410

7.  Fidelity of HIV-1 reverse transcriptase copying RNA in vitro.

Authors:  J P Ji; L A Loeb
Journal:  Biochemistry       Date:  1992-02-04       Impact factor: 3.162

8.  Comparison of HIV-1 and avian myeloblastosis virus reverse transcriptase fidelity on RNA and DNA templates.

Authors:  H Yu; M F Goodman
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

9.  Effect of reaction conditions and 3AB on the mutation rate of poliovirus RNA-dependent RNA polymerase in a alpha-complementation assay.

Authors:  Jeffrey J DeStefano
Journal:  Virus Res       Date:  2009-10-20       Impact factor: 3.303

10.  Mg2+ dependency of HIV-1 reverse transcription, inhibition by nucleoside analogues and resistance.

Authors:  Valérie Goldschmidt; Joël Didierjean; Bernard Ehresmann; Chantal Ehresmann; Catherine Isel; Roland Marquet
Journal:  Nucleic Acids Res       Date:  2006-01-03       Impact factor: 16.971

View more
  14 in total

1.  Physiological Mg2+ Conditions Significantly Alter the Inhibition of HIV-1 and HIV-2 Reverse Transcriptases by Nucleoside and Non-Nucleoside Inhibitors in Vitro.

Authors:  Vasudevan Achuthan; Kamlendra Singh; Jeffrey J DeStefano
Journal:  Biochemistry       Date:  2016-12-27       Impact factor: 3.162

2.  Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication.

Authors:  Siarhei Kharytonchyk; Steven R King; Clement B Ndongmo; Krista L Stilger; Wenfeng An; Alice Telesnitsky
Journal:  J Mol Biol       Date:  2016-04-10       Impact factor: 5.469

3.  Mismatched Primer Extension Assays.

Authors:  Vasudevan Achuthan; Jeffrey J DeStefano
Journal:  Bio Protoc       Date:  2015-06-20

Review 4.  Avoiding Drug Resistance in HIV Reverse Transcriptase.

Authors:  Maria E Cilento; Karen A Kirby; Stefan G Sarafianos
Journal:  Chem Rev       Date:  2021-01-28       Impact factor: 60.622

5.  Alternative divalent cations (Zn²⁺, Co²⁺, and Mn²⁺) are not mutagenic at conditions optimal for HIV-1 reverse transcriptase activity.

Authors:  Vasudevan Achuthan; Jeffrey J DeStefano
Journal:  BMC Biochem       Date:  2015-05-03       Impact factor: 4.059

6.  Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA.

Authors:  Valerie F Boltz; Jason Rausch; Wei Shao; Junko Hattori; Brian Luke; Frank Maldarelli; John W Mellors; Mary F Kearney; John M Coffin
Journal:  Retrovirology       Date:  2016-12-20       Impact factor: 4.602

7.  Diaryl ethers with carboxymethoxyphenacyl motif as potent HIV-1 reverse transcriptase inhibitors with improved solubility.

Authors:  Tomasz Frączek; Rafał Kamiński; Agnieszka Krakowiak; Evelien Naessens; Bruno Verhasselt; Piotr Paneth
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

8.  What do docking and QSAR tell us about the design of HIV-1 reverse transcriptase nonnucleoside inhibitors?

Authors:  Agata Paneth; Wojciech Płonka; Piotr Paneth
Journal:  J Mol Model       Date:  2017-10-19       Impact factor: 1.810

9.  Transcriptional inaccuracy threshold attenuates differences in RNA-dependent DNA synthesis fidelity between retroviral reverse transcriptases.

Authors:  Alba Sebastián-Martín; Verónica Barrioluengo; Luis Menéndez-Arias
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

10.  Primer Extension Reactions for the PCR- based α- complementation Assay.

Authors:  Vasudevan Achuthan; Jeffrey J DeStefano
Journal:  Bio Protoc       Date:  2015-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.